Legend Biotech Market Sentiment

SPY776.55 QQQ752.90+0.71%BTC/USD82,898.97+1.48%DIA512.26 GLD383.40 TLT77.81−0.08%

Premium

Legend Biotech Corp

LEGNNASDAQ

Trade with Public

$18.71

-0.41-2.14%

Last update: Oct 9, 8:17 AM

$18.61

-0.51-2.65%

Overview News Earnings Forecast Events Price Targets FinancialsSentimentOwnership Compare Options Stock Report

Legend Biotech Market Sentiment - Benzinga

Legend Biotech Market Sentiment

Market sentiment signals for Legend Biotech (LEGN): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus— Overweight

Short Interest▲ 17.8% short float

Options Flow— N/A

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Overweight

21 analysts

Options Flow (P/C)

—

Avg Consensus PT

$64

+245.4%

Highest Price Target

$90

+383.5%

BMO Capital

Lowest Price Target

$24

+28.9%

TD Cowen

Short Interest

17.8%

Declining — Bullish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 8, 2026	RBC Capital	Leonid Timashev—	+200.9%	$58 → $56	Maintained	Outperform
Sep 30, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+249.2%	$65 → $65	Maintained	Buy
Sep 11, 2026	Barclays	Etzer Darout—	+297.6%	$78 → $74	Maintained	Overweight
Sep 4, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+249.2%	$65 → $65	Maintained	Buy
Aug 12, 2026	Morgan Stanley	Matthew Harrison—	+163.2%	$48 → $49	Maintained	Overweight
Aug 12, 2026	TD Cowen	Yaron Werber—	+28.9%	$29 → $24	Maintained	Hold
Aug 12, 2026	Oppenheimer	Trevor Allred—	+114.9%	$75 → $40	Downgrade	Outperform→Perform
Aug 12, 2026	RBC Capital	Leonid Timashev—	+211.6%	$59 → $58	Maintained	Outperform
Aug 12, 2026	Barclays	Etzer Darout—	+319.0%	$80 → $78	Maintained	Overweight
Jul 28, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+249.2%	$65 → $65	Maintained	Buy
Jul 27, 2026	RBC Capital	Leonid Timashev—	+217.0%	$63 → $59	Maintained	Outperform
Jul 24, 2026	UBS	Ashwani Verma—	+50.4%	$49 → $28	Downgrade	Buy→Neutral
Jul 13, 2026	JP Morgan	Jessica Fye—	+88.0%	$35	Reinstates	Neutral
Jul 7, 2026	RBC Capital	Leonid Timashev—	+238.5%	$64 → $63	Maintained	Outperform
Jun 3, 2026	UBS	Ashwani Verma—	+163.2%	$31 → $49	Maintained	Buy
Jun 3, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+249.2%	$50 → $65	Maintained	Buy
May 18, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+168.6%	$50 → $50	Maintained	Buy
May 13, 2026	TD Cowen	Yaron Werber—	+55.8%	$21 → $29	Maintained	Hold
May 13, 2026	Morgan Stanley	Matthew Harrison—	+157.9%	$49 → $48	Maintained	Overweight
May 13, 2026	RBC Capital	Leonid Timashev—	+243.8%	$62 → $64	Maintained	Outperform
Apr 21, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+168.6%	$50 → $50	Maintained	Buy
Apr 15, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+168.6%	$50 → $50	Maintained	Buy
Mar 11, 2026	Morgan Stanley	Matthew Harrison—	+163.2%	$50 → $49	Maintained	Overweight
Mar 11, 2026	RBC Capital	Leonid Timashev—	+233.1%	$66 → $62	Maintained	Outperform
Feb 4, 2026	Barclays	Gena Wang—	+329.8%	$90 → $80	Maintained	Overweight